BOCA RATON, FL--(Marketwired - May 3, 2013) - Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO) announced today that it is adding to the expertise on its board of directors with the appointment of Lowell ...

BOCA RATON, FL--(Marketwired - Aug 5, 2014) - Vycor Medical, Inc. ("Vycor" or the "Company") (OTCQB: VYCO), today announces that its largest shareholder, Fountainhead Capital Management Limited ...

Vycor Medical develops devices for neurosurgery and vision rehabilitation. Its main product, the ViewSite Brain Access System (VBAS), is a neurosurgical device designed to enable safer access to areas ...

Visit a quote page and your recently viewed tickers will be displayed here.

B2i Digital to Showcase Vycor Medical's Neurosurgical and Vision Rehabilitation Technologies NEW YORK, NY - March 13, 2025 (NEWMEDIAWIRE) - B2i Digital is pleased to announce that Vycor Medical, Inc. ...

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor ...

Revenue climbed 22% (GAAP) for the three months ended June 30, 2025, compared to the prior year period, largely due to international growth in the Vycor Medical division. Non-GAAP operating profit ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.